Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Bioscience Announces New CFO, COO

NEW YORK, Aug. 19 (GenomeWeb News) -Harvard Biosciences has completed two management changes, naming Susan Luscinski Chief Operating Officer and hiring Bryce Chicoyne as its new Chief Financial officer, the company said late Wednesday.


Luscinski, who has been at the company for the past 20 years, most recently served as CFO. In her new role, Luscinski will now focus on business planning and operations, the company said.


Luscinski "is being promoted because we think she can help us improve operating margin - one of our key operating metrics," David Green, president of Harvard Bioscience, said in an email to GenomeWeb News.


Chicoyne, the new CFO, comes to Harvard Bioscience from Apogent Technologies, where he was the director of financial reporting. His experience includes SEC compliance, financial management, mergers and acquisitions, and debt and equity financing.


These changes follow on the heels of  the company's announcement of flat revenues and dwindling earnings in the second quarter, which it attributed to the Genomic Solutions product line.


The company announced in the second-quarter earnings call that it was cutting 36 employees from the Genomic Solutions unit and shuttering the Genomic Solutions San Carlos, Calif. production site.


The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.